Artesunate 50mg Injection Vials from Mexico
>- Artesunate injection vials contain artesunate, an artemisinin derivative listed in Subheading Note 2, formulated as a lyophilized powder for reconstitution. The product is presented in single-dose vials for therapeutic use in severe malaria. This meets the criteria for tariff item 3004.60.00 as a medicament containing an antimalarial active principle.
Duty Rate — Mexico → Canada
0%
Import Tips
• >- Verify that the vials are registered with Health Canada or qualify for an exemption under the Special Access Programme
• Provide the CBSA with the concentration of artesunate per vial and the intended use to confirm classification
• Ensure cold-chain storage documentation is available if required during transport